Russell D. Cohen to Neoplasms
This is a "connection" page, showing publications Russell D. Cohen has written about Neoplasms.
Connection Strength
0.114
-
The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data. J Crohns Colitis. 2020 Feb 10; 14(2):192-204.
Score: 0.063
-
Sex differentials in morbidity and mortality risks examined by age and cause in the same cohort. Am J Epidemiol. 1989 Sep; 130(3):601-10.
Score: 0.031
-
Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease. Drugs. 2004; 64(16):1767-77.
Score: 0.021